Filing Details
- Accession Number:
- 0001225208-18-015372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-09 17:20:32
- Reporting Period:
- 2018-11-07
- Accepted Time:
- 2018-11-09 17:20:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1673401 | Joaquin Duato | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Vice Chair, Exec Committee | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-07 | 19,293 | $62.20 | 112,848 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-07 | 15,577 | $65.37 | 128,425 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-11-07 | 5,130 | $58.33 | 133,555 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-07 | 40,000 | $144.36 | 93,555 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2018-11-07 | 19,293 | $0.00 | 19,293 | $62.20 |
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2018-11-07 | 15,577 | $0.00 | 15,577 | $65.37 |
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2018-11-07 | 5,130 | $0.00 | 5,130 | $58.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-01-11 | 2021-01-08 | No | 4 | M | Direct |
| 84,423 | 2015-01-18 | 2022-01-17 | No | 4 | M | Direct |
| 0 | 2012-02-10 | 2019-02-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 636 | Indirect | By 401k |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $144.31 to $144.484. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2018).
Billionaire Hedge Funds
